Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tina Schnöder"'
Autor:
Theresa Lowinus, Florian H. Heidel, Tanima Bose, Subbaiah Chary Nimmagadda, Tina Schnöder, Clemens Cammann, Ingo Schmitz, Ulrike Seifert, Thomas Fischer, Burkhart Schraven, Ursula Bommhardt
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-13 (2019)
Abstract Background Treatment of acute leukemia is challenging and long-lasting remissions are difficult to induce. Innovative therapy approaches aim to complement standard chemotherapy to improve drug efficacy and decrease toxicity. Promising new th
Externí odkaz:
https://doaj.org/article/58bd27f1c33f445fa05b8617cf253f3b
Publikováno v:
Toxins, Vol 8, Iss 12, p 366 (2016)
RTA, the catalytic A-subunit of the ribosome inactivating A/B toxin ricin, inhibits eukaryotic protein biosynthesis by depurination of 28S rRNA. Although cell surface binding of ricin holotoxin is mainly mediated through its B-subunit (RTB), sole app
Externí odkaz:
https://doaj.org/article/e293455a50f4409cbb50669dedb873e5
Autor:
Daniel B Lipka, Marie-Christine Wagner, Marek Dziadosz, Tina Schnöder, Florian Heidel, Mirle Schemionek, Junia V Melo, Thomas Kindler, Carsten Müller-Tidow, Steffen Koschmieder, Thomas Fischer
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40853 (2012)
Clinical development of imatinib in CML established continuous target inhibition as a paradigm for successful tyrosine kinase inhibitor (TKI) therapy. However, recent reports suggested that transient potent target inhibition of BCR-ABL by high-dose T
Externí odkaz:
https://doaj.org/article/797e76c3d7354db18c29dbd8b13b1d55
Autor:
Theresa, Lowinus, Florian H, Heidel, Tanima, Bose, Subbaiah Chary, Nimmagadda, Tina, Schnöder, Clemens, Cammann, Ingo, Schmitz, Ulrike, Seifert, Thomas, Fischer, Burkhart, Schraven, Ursula, Bommhardt
Publikováno v:
Cell Communication and Signaling : CCS
Background Treatment of acute leukemia is challenging and long-lasting remissions are difficult to induce. Innovative therapy approaches aim to complement standard chemotherapy to improve drug efficacy and decrease toxicity. Promising new therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07209e40d752b3d27751851a80c9df7e
https://pubmed.ncbi.nlm.nih.gov/30651113
https://pubmed.ncbi.nlm.nih.gov/30651113
Autor:
Lynne M. Roberts, Shuyu Li, Graham Ladds, Stuart C H Allen, Tina Schnöder, Robert A. Spooner, Manfred J. Schmitt, Christopher P. Guise, J. Michael Lord
Publikováno v:
Molecular Biology of the Cell
This study reveals that components of the yeast ERAD-L pathway can discriminate between two subtly different forms of the same toxin substrate. Although precytosolic requirements are similar for both toxin structures, there is a divergence in fate on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc66a606d7ac9c6d8f5f10ad9f2cc967
https://pubmed.ncbi.nlm.nih.gov/20519439
https://pubmed.ncbi.nlm.nih.gov/20519439